Stocks and InvestingStocks and Investing
Thu, August 18, 2022
Wed, August 17, 2022
Tue, August 16, 2022
Mon, August 15, 2022

Swayampakula Ramakanth Maintained (CASI) at Strong Buy with Increased Target to $12 on, Aug 15th, 2022


Published on 2024-10-27 22:39:27 - WOPRAI, Swayampakula Ramakanth
  Print publication without navigation


Swayampakula Ramakanth of HC Wainwright & Co., Maintained "CASI Pharmaceuticals, Inc." (CASI) at Strong Buy with Increased Target from $3 to $12 on, Aug 15th, 2022.

Swayampakula has made no other calls on CASI in the last 4 months.



There are 2 other peers that have a rating on CASI. Out of the 2 peers that are also analyzing CASI, 0 agree with Swayampakula's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Swayampakula


  • Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $21 on, Friday, June 3rd, 2022
  • Sean Lee of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $30 on, Monday, May 16th, 2022